Zobrazeno 1 - 10
of 371
pro vyhledávání: '"Antiresorptive Drugs"'
Publikováno v:
Journal of Dental Sciences, Vol 19, Iss 4, Pp 2448-2451 (2024)
Externí odkaz:
https://doaj.org/article/b0e230afe7fe4dcdacf5549b152a277e
Autor:
Puria Parvini, Karina Obreja, Emilio A. Cafferata, Tuba Aini, Yanislava Lermen, Amira Begic, Robert Sader, Frank Schwarz
Publikováno v:
BMC Oral Health, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Antiresorptive therapy (AR) disrupts osseous homeostasis and can induce direct irritation over the gastrointestinal mucosa; however, its possible erosive effects on the oral epithelium have not been totally described. Among the mo
Externí odkaz:
https://doaj.org/article/fa445bbbfe604853b1c4d70075e1295b
Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw
Autor:
Katharina Theresa Obermeier, Ina Dewenter, Yoana Malenova, Riham Fliefel, Gabriele Kaeppler, Sven Otto
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction associated with antiresorptive drugs such as bisphosphonates and denosumab. When dealing with advanced and/or multiple MRONJ lesions undergoing surgical therap
Externí odkaz:
https://doaj.org/article/512d8e85cfa84f9991722323a26ea787
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Prior research has indicated that bisphosphonates (BPs) can improve periodontal disease because of their anti-osteoporosis properties. In vitro studies have shown that BPs induce cytotoxicity, inhibit wound healing, and thus affect periodontal diseas
Externí odkaz:
https://doaj.org/article/aceff6137ad04fceb69f5ee94ac2f2c0
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The occurrence of bone metastasis is a grave medical concern that substantially impacts the quality of life in patients with cancer. The precise mechanisms underlying bone metastasis remain unclear despite extensive research efforts, and efficacious
Externí odkaz:
https://doaj.org/article/fdfc9279e2e4465cbb553801c5bc957b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Bolʹ, Sustavy, Pozvonočnik, Vol 12, Iss 2, Pp 46-51 (2022)
Introduction. Despite the recent ASBMR, AACE, Endocrine Society, ECTS&NOF guidelines for osteoporosis management in the era of COVID-19 the impact of antiosteoporotic drugs on disease risk and severity is insufficiently studied. The purpose of this s
Externí odkaz:
https://doaj.org/article/06621ef25b5b4cfd82eb44b3c356f6d9
Autor:
Tai Pang Ip
Publikováno v:
Journal of Clinical Rheumatology and Immunology, Vol 22, Iss Supp01, Pp 10-19 (2022)
Osteoporosis is the most common metabolic bone disease and constitutes a major public health problem all over the world. Most international clinical practice guidelines have conventionally positioned the class of antiresorptive drugs, the bisphosphon
Externí odkaz:
https://doaj.org/article/f42bcf9084d9466ba84b480f753dbe7b
Autor:
Daniela Cia Penoni, João Vitor S. Canellas, Marcos Antonio Nunes Costa Silami, Flávia Sader, Gonçalo Sobreira Pimentel Neto, Anna Thereza Thomé Leão
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 67, Iss 4 (2023)
ABSTRACT Objective: This study aimed to report the experience of medication-related osteonecrosis of the jaws (MRONJ) in osteoporotic patients for nine years, and their associated initiating factors. Materials and methods: The numbers of invasive ora
Externí odkaz:
https://doaj.org/article/e095f9e3d93f4862a246a30398f715bf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.